GB0406546D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB0406546D0
GB0406546D0 GB0406546A GB0406546A GB0406546D0 GB 0406546 D0 GB0406546 D0 GB 0406546D0 GB 0406546 A GB0406546 A GB 0406546A GB 0406546 A GB0406546 A GB 0406546A GB 0406546 D0 GB0406546 D0 GB 0406546D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0406546A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0406546A priority Critical patent/GB0406546D0/en
Publication of GB0406546D0 publication Critical patent/GB0406546D0/en
Priority claimed from US10/563,668 external-priority patent/US20060167027A1/en
Priority claimed from CN 200480025738 external-priority patent/CN100425240C/en
Application status is Ceased legal-status Critical

Links

GB0406546A 2004-03-24 2004-03-24 Combination therapy Ceased GB0406546D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0406546A GB0406546D0 (en) 2004-03-24 2004-03-24 Combination therapy

Applications Claiming Priority (20)

Application Number Priority Date Filing Date Title
GB0406546A GB0406546D0 (en) 2004-03-24 2004-03-24 Combination therapy
US10/563,668 US20060167027A1 (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
NZ54445804A NZ544458A (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative ZD6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
BRPI0412426 BRPI0412426A (en) 2003-07-10 2004-07-07 Use of ZD6474 or a pharmaceutically acceptable salt thereof and a platinum anti-tumor agent, pharmaceutical composition, kit and method for the production of an antiangiogenic and / or vascular permeability reducing agent in a warm blooded animal
KR1020067000464A KR20060033782A (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
CN 200480025738 CN100425240C (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative ZD6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeabi
AT04743275T AT478671T (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative vascular permeability ZD6474 in combination with platinum compounds and optional ionizing radiation in the treatment of diseases associated with angiogenesis and / or increased
DE200460028834 DE602004028834D1 (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative vascular permeability ZD6474 in combination with platinum compounds and optional ionizing radiation in the treatment of diseases associated with angiogenesis and / or increased
JP2006518352A JP2007526886A (en) 2003-07-10 2004-07-07 In the treatment of angiogenesis and / or vascular hyperpermeability in diseases associated with the use of a quinazoline derivative zd6474 in combination platinum-based antineoplastic agents and any ionizing radiation
KR1020127017256A KR20120093411A (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
MXPA06000114A MXPA06000114A (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability.
AU2004255022A AU2004255022B2 (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative ZD6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
EP20040743275 EP1648465B1 (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
PCT/GB2004/002932 WO2005004870A1 (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
CA 2531862 CA2531862C (en) 2003-07-10 2004-07-07 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
IL17285305A IL172853A (en) 2003-07-10 2005-12-27 Use of the quinazoline derivative zd6474 combined with a platinum anti tumor agent in the manufacture of medicaments for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm blooded animal and pharmaceutical compositions and kits comprising such combination
NO20060307A NO333122B1 (en) 2003-07-10 2006-01-20 Use of 4- (4-bromo-2-fluoroanilino) -6-methoxy-7- (1-methylpiperidin-4-ylmethoxy) quinazoline combination with platinum compounds in the manufacture of medicaments for a producing an anti-cancer effect or antitumor effect in a warm-blooded animal said as a human and to pharmaceutical compositions containing same
HK06109909A HK1089378A1 (en) 2003-07-10 2006-09-06 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
US12/624,760 US20100215773A1 (en) 2003-07-10 2009-11-24 Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability
US13/294,152 US20120263802A1 (en) 2003-07-10 2011-11-10 Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability

Publications (1)

Publication Number Publication Date
GB0406546D0 true GB0406546D0 (en) 2004-04-28

Family

ID=32188555

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0406546A Ceased GB0406546D0 (en) 2004-03-24 2004-03-24 Combination therapy

Country Status (1)

Country Link
GB (1) GB0406546D0 (en)

Similar Documents

Publication Publication Date Title
TWI346544B (en) Knochenschraube
DE602005003960D1 (en) Oximesther-fotoinitiatoren
DE602005017576D1 (en) Wirbel-osteosynthese-gerät
DE602005025924D1 (en) Royl-coa-desaturase
EP1769743A4 (en) Radiotomograph
DE602005025220D1 (en) Thernet-kabel
DE602005022165D1 (en) Fluidleitungsverbindervorrichtung
DE602005003667D1 (en) Sandwich-hybridmontagematte
DE602005020252D1 (en) Röhrenförmige prothese
EP1962961A4 (en) Demibodies: dimerisation-activated therapeutic agents
EP1730148A4 (en) Aminobenzoxazoles as therapeutic agents
TWI334865B (en) 4-phenylamino-quinazolin-6-yl-amides
GB0415112D0 (en) Therapeutic device
DE502005007844D1 (en) Phasenstabile polyurethanprepolymere
GB0423554D0 (en) Therapeutic compounds
DE602005007474D1 (en) Substituierte morpholin- und thiomorpholinderivate
SI2251330T1 (en) 4-Hydroxybenzomorphans
GB0413087D0 (en) Therapeutic compounds
EP1793751A4 (en) Compressor-distractor
DE602005010905D1 (en) Roboterhandvorrichtung
GB0508471D0 (en) Therapeutic agents
GB0416396D0 (en) Therapeutic agents
GB0504828D0 (en) Therapeutic agents
PL1593299T3 (en) Rotobaler
GB0419850D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)